secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001493152-23-018160
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics updates shelf offering to sell up to $38.9M in common shares
--------------------------------------------------------------------------------

- Offering up to $38,856,704 of common shares under previously effective Form S-3 registration statement.
- Prospectus supplement filed May 18, 2023, updating the Controlled Equity Offering agreement with Cantor Fitzgerald & Co.
- Legal opinion from Sheppard, Mullin, Richter & Hampton LLP on share validity included as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315223018160/0001493152-23-018160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315223018160/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer